The Determinants of Endothelial Dysfunction in CKD: Oxidative Stress and Asymmetric Dimethylarginine-Reference-Cited by-同舟云学术

The Determinants of Endothelial Dysfunction in CKD: Oxidative Stress and Asymmetric Dimethylarginine

Published:2006-01 Issue:1 Volume:47 Page:42-50
ISSN:0272-6386
Container-title:American Journal of Kidney Diseases
language:en
Short-container-title:American Journal of Kidney Diseases

Author:

Yilmaz Mahmut Ilker,Saglam Mutlu,Caglar Kayser,Cakir Erdinc,Sonmez Alper,Ozgurtas Taner,Aydin Ahmet,Eyileten Tayfun,Ozcan Omer,Acikel Cengizhan,Tasar Mustafa,Genctoy Gultekin,Erbil Kemal,Vural Abdulgaffar,Zoccali Carmine

Publisher

Elsevier BV

Subject

Nephrology

Reference46 articles.

1. Cardiovascular disease in chronic renal failure: The challenge continues. Registro Lombardo Dialisi e Trapianto;Locatelli;Nephrol Dial Transplant,2000

2. Cardiovascular risk factors in chronic renal failure and hemodialysis populations;Ma;Am J Kidney Dis,1992

3. Premature cardiovascular disease in chronic renal failure;Baigent;Lancet,2000

4. Oxidative stress in end-stage renal disease;Locatelli;Nephrol Dial Transplant,2003

5. Serum concentrations of asymmetric (ADMA) and symmetric (SDMA) dimethylarginine in patients with chronic kidney diseases;Fleck;Clin Chim Acta,2003

Cited by 283 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Asymmetric dimethylarginine serum concentration in normal weight and obese CKD patients treated with hemodialysis;BMC Nephrology;2024-09-05

2. The microbial metabolite p-cresol compromises the vascular barrier and induces endothelial cytotoxicity and inflammation in a 3D human vessel-on-a-chip;Scientific Reports;2024-08-09

3. The Significance of Endothelial Dysfunction in Long COVID-19 for the Possible Future Pandemic of Chronic Kidney Disease and Cardiovascular Disease;Biomolecules;2024-08-08

4. Vitamin D therapy in chronic kidney disease: a critical appraisal of clinical trial evidence;Clinical Kidney Journal;2024-07-18

5. Bariatric surgery modulates plasma levels of antibodies against angiotensin II type 1 and endothelin 1 type A receptor in severe obesity;Journal of Endocrinological Investigation;2024-06-20